Gilead Sciences (GILD) Tops Q4 EPS by 4c, Offers FY Guidance

February 4, 2021 4:03 PM EST
Get Alerts GILD Hot Sheet
Price: $65.90 -0.08%

Revenue Growth %: +20.9%

Financial Fact:
Product sales: 7.41B

Today's EPS Names:
MLI, PG, EDU, More
Trade Now! 
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Gilead Sciences (NASDAQ: GILD) reported Q4 EPS of $2.19, $0.04 better than the analyst estimate of $2.15. Revenue for the quarter came in at $7.42 billion versus the consensus estimate of $7.33 billion.


Gilead Sciences sees FY2021 EPS of $6.75-$7.45, versus the consensus of $7.05.

  • Product Sales including Veklury of $23.7 billion to $25.1 billion -
  • - Operating expenses flat to low single-digit percentage decline -

For earnings history and earnings-related data on Gilead Sciences (GILD) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance

Related Entities